These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34733866)

  • 1. Lung Tissue Microbiome Is Associated With Clinical Outcomes of Idiopathic Pulmonary Fibrosis.
    Yoon HY; Moon SJ; Song JW
    Front Med (Lausanne); 2021; 8():744523. PubMed ID: 34733866
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.
    Takahashi Y; Saito A; Chiba H; Kuronuma K; Ikeda K; Kobayashi T; Ariki S; Takahashi M; Sasaki Y; Takahashi H
    Respir Res; 2018 Feb; 19(1):34. PubMed ID: 29486761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
    Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
    Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
    O'Dwyer DN; Kim JS; Ma SF; Ranjan P; Das P; Lipinski JH; Metcalf JD; Falkowski NR; Yow E; Anstrom K; Dickson RP; Huang Y; Gilbert JA; Martinez FJ; Noth I
    Am J Respir Crit Care Med; 2024 May; 209(9):1101-1110. PubMed ID: 38051927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cell profiles of bronchoalveolar lavage fluid as prognostic indicators of idiopathic pulmonary fibrosis].
    Peng SC; Li ZH; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):260-3. PubMed ID: 18846961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal Lung Quantification in Usual Interstitial Pneumonia Pattern: The Impact of Threshold-based Volumetric CT Analysis for the Staging of Idiopathic Pulmonary Fibrosis.
    Ohkubo H; Kanemitsu Y; Uemura T; Takakuwa O; Takemura M; Maeno K; Ito Y; Oguri T; Kazawa N; Mikami R; Niimi A
    PLoS One; 2016; 11(3):e0152505. PubMed ID: 27031615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Mazur W; Miura S; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Res; 2020 Jun; 21(1):145. PubMed ID: 32527263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.
    Tong X; Su F; Xu X; Xu H; Yang T; Xu Q; Dai H; Huang K; Zou L; Zhang W; Pei S; Xiao F; Li Y; Wang C
    Front Cell Infect Microbiol; 2019; 9():149. PubMed ID: 31165050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
    Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.
    Vercauteren IM; Verleden SE; McDonough JE; Vandermeulen E; Ruttens D; Lammertyn EJ; Bellon H; De Dycker E; Dooms C; Yserbyt J; Verleden GM; Vanaudenaerde BM; Wuyts WA
    Exp Lung Res; 2015; 41(8):459-65. PubMed ID: 26381718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
    Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.
    Snyder L; Neely ML; Hellkamp AS; O'Brien E; de Andrade J; Conoscenti CS; Leonard T; Bender S; Gulati M; Culver DA; Kaner RJ; Palmer S; Kim HJ;
    Respir Res; 2019 May; 20(1):105. PubMed ID: 31142314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis.
    Song H; Sun D; Ban C; Liu Y; Zhu M; Ye Q; Yan W; Ren Y; Dai H
    Med Sci Monit; 2019 Jun; 25():4193-4201. PubMed ID: 31166938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.
    Invernizzi R; Wu BG; Barnett J; Ghai P; Kingston S; Hewitt RJ; Feary J; Li Y; Chua F; Wu Z; Wells AU; George PM; Renzoni EA; Nicholson AG; Rice A; Devaraj A; Segal LN; Byrne AJ; Maher TM; Lloyd CM; Molyneaux PL
    Am J Respir Crit Care Med; 2021 Feb; 203(3):339-347. PubMed ID: 32692582
    [No Abstract]   [Full Text] [Related]  

  • 19. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
    Han MK; Zhou Y; Murray S; Tayob N; Noth I; Lama VN; Moore BB; White ES; Flaherty KR; Huffnagle GB; Martinez FJ;
    Lancet Respir Med; 2014 Jul; 2(7):548-56. PubMed ID: 24767767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.